# EDGAR Filing Document

**Accession Number:** 0001614838
**File Stem:** 0001614838-26-000006
**Filing Date:** 2026-3
**Character Count:** 7767
**Document Hash:** 47b85f63911a68de2792a634038e86fc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001614838-26-000006.hdr.sgml**: 20260327

**ACCESSION NUMBER**: 0001614838-26-000006

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260325

**FILED AS OF DATE**: 20260327

**DATE AS OF CHANGE**: 20260327

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Neeleman Stephen
- **CENTRAL INDEX KEY:** 0001614838

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36568
- **FILM NUMBER:** 26808708

**MAIL ADDRESS:**
- **STREET 1:** 15 W. SCENIC POINTE DR., STE. 100
- **CITY:** DRAPER
- **STATE:** UT
- **ZIP:** 84020
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HEALTHEQUITY, INC.
- **CENTRAL INDEX KEY:** 0001428336
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-BUSINESS SERVICES, NEC [7389]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0131

**BUSINESS ADDRESS:**
- **STREET 1:** 15 WEST SCENIC POINTE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** DRAPER
- **STATE:** UT
- **ZIP:** 84020
- **BUSINESS PHONE:** 801-727-1000

**MAIL ADDRESS:**
- **STREET 1:** 15 WEST SCENIC POINTE DRIVE
- **STREET 2:** SUITE 100
- **CITY:** DRAPER
- **STATE:** UT
- **ZIP:** 84020

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HEALTHEQUITY INC
- **DATE OF NAME CHANGE:** 20080227

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Neeleman Stephen<br><sub>(Last) (First) (Middle)</sub><br>C/O HEALTHEQUITY, INC.<br>15 W. SCENIC POINTE DR., STE. 100<br><sub>(Street)</sub><br>DRAPER, UT 84020<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-25 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_FOUNDER AND VICE CHAIRMAN_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>HEALTHEQUITY, INC. [ HQY ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-03-25 |  | A |  | 15915<sup>(1)</sup> | A | $0 | 126659 | D |  |
| Common Stock | 2026-03-25 |  | A |  | 23860<sup>(2)</sup> | A | $0 | 150519 | D |  |
| Common Stock |  |  |  |  |  |  |  | 409735 | I | See footnote<sup>(3)</sup> |
| Common Stock |  |  |  |  |  |  |  | 140000 | I | See footnote<sup>(4)</sup> |
| Common Stock |  |  |  |  |  |  |  | 203000 | I | See footnote<sup>(5)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option (right to buy) | $41.28 |  |  |  |  |  |  | <sup>(6)</sup> | 2027-03-27 | Common Stock | 19897 |  | 19897 | D |  |
| Stock Options (right to buy) | $61.72 |  |  |  |  |  |  | <sup>(6)</sup> | 2028-03-27 | Common Stock | 14228 |  | 14228 | D |  |
| Stock Options (right  to buy) | $73.61 |  |  |  |  |  |  | <sup>(6)</sup> | 2029-03-26 | Common Stock | 15337 |  | 15337 | D |  |

---

### Footnotes:

(1) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Shares vest as to 25% of the initial award on April 1, 2027. Shares shall vest as to 6.25% thereafter on the first day of each calendar quarter for the twelve calendar quarters following April 1, 2027.

(2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 23,860 shares on March 25, 2026.

(3) Shares held of record by the Stephen and Christine Neeleman Trust.

(4) The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

(5) Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

(6) The option is immediately exercisable.

**Signature:** /s/ Stephen Neeleman  
**Date:** 2026-03-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**